BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 28134258)

  • 1. SUMO and the robustness of cancer.
    Seeler JS; Dejean A
    Nat Rev Cancer; 2017 Mar; 17(3):184-197. PubMed ID: 28134258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage.
    Wuerzberger-Davis SM; Nakamura Y; Seufzer BJ; Miyamoto S
    Oncogene; 2007 Feb; 26(5):641-51. PubMed ID: 16862178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SUMOylation attenuates sensitivity toward hypoxia- or desferroxamine-induced injury by modulating adaptive responses in salivary epithelial cells.
    Nguyen HV; Chen JL; Zhong J; Kim KJ; Crandall ED; Borok Z; Chen Y; Ann DK
    Am J Pathol; 2006 May; 168(5):1452-63. PubMed ID: 16651613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of SUMO in pancreatic beta-cells.
    Ehninger A; Mziaut H; Solimena M
    Horm Metab Res; 2007 Sep; 39(9):658-64. PubMed ID: 17846973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small ubiquitin-related modifier-1 modification regulates all-trans-retinoic acid-induced differentiation via stabilization of retinoic acid receptor α.
    Zhou Q; Zhang L; Chen Z; Zhao P; Ma Y; Yang B; He Q; Ying M
    FEBS J; 2014 Jul; 281(13):3032-47. PubMed ID: 24819975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress of small ubiquitin-related modifiers in kidney diseases.
    Li O; Ma Q; Li F; Cai GY; Chen XM; Hong Q
    Chin Med J (Engl); 2019 Feb; 132(4):466-473. PubMed ID: 30707172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMOylation and cell signalling.
    Andreou AM; Tavernarakis N
    Biotechnol J; 2009 Dec; 4(12):1740-52. PubMed ID: 19946876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.
    Mabb AM; Wuerzberger-Davis SM; Miyamoto S
    Nat Cell Biol; 2006 Sep; 8(9):986-93. PubMed ID: 16906147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMO-regulated transcription: challenging the dogma.
    Chymkowitch P; Nguéa P A; Enserink JM
    Bioessays; 2015 Oct; 37(10):1095-105. PubMed ID: 26354225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Something about SUMO inhibits transcription.
    Gill G
    Curr Opin Genet Dev; 2005 Oct; 15(5):536-41. PubMed ID: 16095902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global shifts in protein sumoylation in response to electrophile and oxidative stress.
    Manza LL; Codreanu SG; Stamer SL; Smith DL; Wells KS; Roberts RL; Liebler DC
    Chem Res Toxicol; 2004 Dec; 17(12):1706-15. PubMed ID: 15606148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel link between SUMO modification and cancer metastasis.
    Baek SH
    Cell Cycle; 2006 Jul; 5(14):1492-5. PubMed ID: 16861889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO: a regulator of gene expression and genome integrity.
    Müller S; Ledl A; Schmidt D
    Oncogene; 2004 Mar; 23(11):1998-2008. PubMed ID: 15021887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMOylated CPAP is required for IKK-mediated NF-κB activation and enhances HBx-induced NF-κB signaling in HCC.
    Yang ST; Yen CJ; Lai CH; Lin YJ; Chang KC; Lee JC; Liu YW; Chang-Liao PY; Hsu LS; Chang WC; Hung WC; Tang TK; Liu YW; Hung LY
    J Hepatol; 2013 Jun; 58(6):1157-64. PubMed ID: 23369793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of SUMO/Ubc9 in DNA damage repair and tumorigenesis.
    Moschos SJ; Mo YY
    J Mol Histol; 2006 Sep; 37(5-7):309-19. PubMed ID: 16758298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High glucose induces activation of NF-κB inflammatory signaling through IκBα sumoylation in rat mesangial cells.
    Huang W; Xu L; Zhou X; Gao C; Yang M; Chen G; Zhu J; Jiang L; Gan H; Gou F; Feng H; Peng J; Xu Y
    Biochem Biophys Res Commun; 2013 Aug; 438(3):568-74. PubMed ID: 23911785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SUMOylation attenuates the transcriptional activity of the NF-κB subunit RelB.
    Leidner J; Voogdt C; Niedenthal R; Möller P; Marienfeld U; Marienfeld RB
    J Cell Biochem; 2014 Aug; 115(8):1430-40. PubMed ID: 24616021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral ischemia/stroke and small ubiquitin-like modifier (SUMO) conjugation--a new target for therapeutic intervention?
    Yang W; Sheng H; Homi HM; Warner DS; Paschen W
    J Neurochem; 2008 Aug; 106(3):989-99. PubMed ID: 18410505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO: a ubiquitin-like protein modifier.
    Kroetz MB
    Yale J Biol Med; 2005 Jul; 78(4):197-201. PubMed ID: 16720014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear and unclear functions of SUMO.
    Seeler JS; Dejean A
    Nat Rev Mol Cell Biol; 2003 Sep; 4(9):690-9. PubMed ID: 14506472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.